In 2006, the United States spent about $2.1 trillion on health care. With an aging population that's increasing in number, and escalating costs of medical care and technology, that figure is expected to grow 6.7% annually to reach $4.3 trillion in 2017.
With that in mind, I used our new CAPS screening tool to find out which health-care stocks the CAPS investing community is the most bullish on.
These stocks also have:
- Market caps greater than $1 billion.
- Five-star ratings, the highest possible, from our CAPS community.
Remember, in the first year for which we have data, five-star companies outperformed with an average gain of nearly 28%.
|
Company |
Share Price |
Market Cap
|
|---|---|---|
|
Amedisys |
$52.41 |
$1.4 |
|
China Medical (NASDAQ:CMED) |
$39.30 |
$1.1 |
|
Genzyme (NASDAQ:GENZ) |
$68.43 |
$18.3 |
|
Gilead Sciences (NASDAQ:GILD) |
$53.87 |
$49.7 |
|
Hologic (NASDAQ:HOLX) |
$22.09 |
$5.6 |
|
Johnson & Johnson |
$66.15 |
$186.4 |
|
Meridian Bioscience |
$29.28 |
$1.2 |
|
Mindray Medical (NYSE:MR) |
$37.63 |
$4.0 |
|
Stryker (NYSE:SYK) |
$62.30 |
$25.7 |
|
Teva Pharmaceutical (NASDAQ:TEVA) |
$45.93 |
$35.6 |
Data from Motley Fool CAPS and Yahoo! Finance as of May 20.
Of course, true Fools know that it takes more than a screen to generate healthy returns. Come and join us on Motley Fool CAPS, where the collective wisdom of our 105,000-strong CAPS community can help you make your investment decisions.
If you’re looking for more investment ideas, try our Rule Breakers growth-stock newsletter. You can read all our past recommendations, including our favorite opportunities in health care and medicine, free for 30 days, with no obligation.
For more Foolish content:
